Pablo García Feijoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Pablo García Feijoo has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Miguel Sáez-Alegre
Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota, USA
5 shared publications - Catalina Vivancos Sánchez
Department of Neurosurgery, Hospital Universitario La Paz, Madrid, Spain
4 shared publications - Víctor Rodríguez Domínguez
Neurosurgical Department, La Paz Hospital
4 shared publications Alberto Isla
Department of Neurosurgery, Hospital Universitario La Paz [La Paz University Hospital], Madrid, Spain
3 shared publications- Carlos Pérez-López
Research Area, Consorci Sanitari Alt Penedès i Garraf, Barcelona, Spain
3 shared publications Susana Santiago
Clinical Neurophysiology, Neurology Department, Hospital Universitario La Paz, Madrid, Spain
3 shared publications
Latest Publications
- 20 March 2026
- Published by Elsevier in Neurocirugía (English Edition)
- Vol. 37 (5) , 500755
Brachial plexus tumours: Diagnosis, treatment, surgical approach, and outcomes in a series of 47 patients
- 20 March 2026
- Published by Elsevier in Neurocirugía (English Edition)
- Vol. 37 (5) , 500755
Brachial plexus tumours: Diagnosis, treatment, surgical approach, and outcomes in a series of 47 patients
- 4 December 2025
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 32 (8)
Disseminated paracoccidioidomycosis in a migrant from Paraguay
Highlights: Disseminated paracoccidioidomycosis was diagnosed in a Paraguayan migrant presenting with pulmonary, adrenal and central nervous system involvement. Diagnosis was confirmed by histopathology, RT-qPCR and culture. Early recognition and combined antifungal therapy are crucial for management, underscoring the need to consider endemic mycoses in migrants from Latin America.
- 4 December 2025
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 32 (8)
Disseminated paracoccidioidomycosis in a migrant from Paraguay
Highlights: Disseminated paracoccidioidomycosis was diagnosed in a Paraguayan migrant presenting with pulmonary, adrenal and central nervous system involvement. Diagnosis was confirmed by histopathology, RT-qPCR and culture. Early recognition and combined antifungal therapy are crucial for management, underscoring the need to consider endemic mycoses in migrants from Latin America.
- 8 June 2024
- Published by Springer Nature in Endocrine
- Vol. 86 (1) , 333-341
Exploring risk factors of severe pituitary apoplexy: Insights from a multicenter study of 71 cases
Purpose To identify clinical and radiological factors associated with a higher risk of developing a severe pituitary apoplexy (PA). Methods Multicenter retrospective study of patients presenting with clinical PA in three Spanish tertiary hospitals of Madrid between 2008 and 2022. We classified PA as severe when presenting with an altered level of consciousness (Glasgow Coma Scale (GCS) < 15) or visual involvement. Results A total of 71 PA cases were identified, of whom 80.28% (n = 57) were classified as severe PA. The median age was 60 (18 to 85 years old) and 67.6% (n = 48) were male. Most patients had macroadenomas, except for one patient with a microadenoma of 9 mm. Headache was the most common presenting symptom (90.1%) and anticoagulation was the most frequent predisposing risk factor, but it was not associated with a higher risk for severe PA (odds ratio [OR] 1.13 [0.21–5.90]). Severe cases were associated with male gender (OR 5.53 [1.59–19.27]), tumor size >20 mm (OR 17.67 [4.07–76.64]), and Knosp grade ≥2 (OR 9.6 [2.38–38.73]). In the multivariant analysis, the only variables associated with a higher risk for severe PA were tumor size and Knosp grade. Surgery was more common in severe PA than in non-severe (91.2% vs. 64.3%, P = 0.009). Conclusion A tumor size >20 mm and cavernous sinus invasion are risk factors for developing a severe PA. These risk factors can stratify patients at a higher risk of a worse clinical picture, and subsequently, more need of decompressive surgery.
- 8 June 2024
- Published by Springer Nature in Endocrine
- Vol. 86 (1) , 333-341
Exploring risk factors of severe pituitary apoplexy: Insights from a multicenter study of 71 cases
Purpose To identify clinical and radiological factors associated with a higher risk of developing a severe pituitary apoplexy (PA). Methods Multicenter retrospective study of patients presenting with clinical PA in three Spanish tertiary hospitals of Madrid between 2008 and 2022. We classified PA as severe when presenting with an altered level of consciousness (Glasgow Coma Scale (GCS) < 15) or visual involvement. Results A total of 71 PA cases were identified, of whom 80.28% (n = 57) were classified as severe PA. The median age was 60 (18 to 85 years old) and 67.6% (n = 48) were male. Most patients had macroadenomas, except for one patient with a microadenoma of 9 mm. Headache was the most common presenting symptom (90.1%) and anticoagulation was the most frequent predisposing risk factor, but it was not associated with a higher risk for severe PA (odds ratio [OR] 1.13 [0.21–5.90]). Severe cases were associated with male gender (OR 5.53 [1.59–19.27]), tumor size >20 mm (OR 17.67 [4.07–76.64]), and Knosp grade ≥2 (OR 9.6 [2.38–38.73]). In the multivariant analysis, the only variables associated with a higher risk for severe PA were tumor size and Knosp grade. Surgery was more common in severe PA than in non-severe (91.2% vs. 64.3%, P = 0.009). Conclusion A tumor size >20 mm and cavernous sinus invasion are risk factors for developing a severe PA. These risk factors can stratify patients at a higher risk of a worse clinical picture, and subsequently, more need of decompressive surgery.
- 20 June 2023
- Published by Elsevier in Neurocirugia
- Vol. 34, S109
P-068 - VARÓN DE 47 AÑOS CON CUADRO DE MIELOPATÍA SUBAGUDA SECUNDARIO A OSIFICACIÓN DEL LIGAMENTO AMARILLO EN LA COLUMNA CERVICAL
- 20 June 2023
- Published by Elsevier in Neurocirugia
- Vol. 34, S109
P-068 - VARÓN DE 47 AÑOS CON CUADRO DE MIELOPATÍA SUBAGUDA SECUNDARIO A OSIFICACIÓN DEL LIGAMENTO AMARILLO EN LA COLUMNA CERVICAL
- 1 November 2022
- Published by Elsevier in Neurocirugia
- Vol. 33 (6) , 284-292
Treatment of cervical myelopathy by posterior approach: Laminoplasty vs. laminectomy with posterior fixation, are there differences from a clinical and radiological point of view?
- 1 November 2022
- Published by Elsevier in Neurocirugia
- Vol. 33 (6) , 284-292
Treatment of cervical myelopathy by posterior approach: Laminoplasty vs. laminectomy with posterior fixation, are there differences from a clinical and radiological point of view?
- Open Access
- 18 April 2022
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 9, 884675
Beyond Classic Anastomoses Training Models: Overview of Aneurysm Creation in Rodent Vessel Model
Nowadays, due to the decline in the number of microsurgical clippings for cerebral aneurysms and revascularization procedures, young neurosurgeons have fewer opportunities to participate and train on this type of surgery. Vascular neurosurgery is a demanding subspecialty that requires skills that can only be acquired with technical experience. This background pushes the new generations to be ready for such challenging cases by training hard on different available models, such as synthetic tubes, chicken wings, or placenta vessels. Although many training models for vascular neurosurgery have been described worldwide, one of the best is the rodent vessels model. It offers pulsation, coagulation, and real blood flow conditions in a physiologic atmosphere that mimics perfectly the intracranial human vessels environment, especially in terms of size. However, the current differences in governmental different regulations about the use of living animals in medical experimentation and the social awareness, as well as the lack of financial support, cause more difficulties for neurosurgeons to start with that kind of training. In this review, we describe the tools and techniques as basic steps for vascular microsurgery training by using rodent models, that provide an accurate copy of brain vessels environment under stable conditions. The initial three classical known microanastomoses for neurosurgeons are end-to-end, end-to-side, and side-to-side, but in literature, there have been described other more complex exercises for training and investigation, such as aneurysm models. Although there is still little data available, we aim to summarize and discuss aneurysm's training models and reviewed the current literature on the subject and its applications, including a detailed description of the techniques.
- 18 April 2022
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 9, 884675
Open AccessBeyond Classic Anastomoses Training Models: Overview of Aneurysm Creation in Rodent Vessel Model
Nowadays, due to the decline in the number of microsurgical clippings for cerebral aneurysms and revascularization procedures, young neurosurgeons have fewer opportunities to participate and train on this type of surgery. Vascular neurosurgery is a demanding subspecialty that requires skills that can only be acquired with technical experience. This background pushes the new generations to be ready for such challenging cases by training hard on different available models, such as synthetic tubes, chicken wings, or placenta vessels. Although many training models for vascular neurosurgery have been described worldwide, one of the best is the rodent vessels model. It offers pulsation, coagulation, and real blood flow conditions in a physiologic atmosphere that mimics perfectly the intracranial human vessels environment, especially in terms of size. However, the current differences in governmental different regulations about the use of living animals in medical experimentation and the social awareness, as well as the lack of financial support, cause more difficulties for neurosurgeons to start with that kind of training. In this review, we describe the tools and techniques as basic steps for vascular microsurgery training by using rodent models, that provide an accurate copy of brain vessels environment under stable conditions. The initial three classical known microanastomoses for neurosurgeons are end-to-end, end-to-side, and side-to-side, but in literature, there have been described other more complex exercises for training and investigation, such as aneurysm models. Although there is still little data available, we aim to summarize and discuss aneurysm's training models and reviewed the current literature on the subject and its applications, including a detailed description of the techniques.
- 1 March 2022
- Published by Elsevier in Neurocirugia
- Vol. 33 (2) , 53-60
Surgery of neurogenic tumors of the sacrum
- 1 March 2022
- Published by Elsevier in Neurocirugia
- Vol. 33 (2) , 53-60
Surgery of neurogenic tumors of the sacrum
- 1 March 2022
- Published by Elsevier in Neurocirugia
- Vol. 33 (2) , 53-60
Cirugía de los tumores neurales del sacro
- 1 March 2022
- Published by Elsevier in Neurocirugia
- Vol. 33 (2) , 53-60
Cirugía de los tumores neurales del sacro
- Open Access
- 25 May 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (6) , 599
Serum Amyloid A1/Toll-Like Receptor-4 Axis, an Important Link between Inflammation and Outcome of TBI Patients
Traumatic brain injury (TBI) is one of the leading causes of mortality and disability worldwide without any validated biomarker or set of biomarkers to help the diagnosis and evaluation of the evolution/prognosis of TBI patients. To achieve this aim, a deeper knowledge of the biochemical and pathophysiological processes triggered after the trauma is essential. Here, we identified the serum amyloid A1 protein-Toll-like receptor 4 (SAA1-TLR4) axis as an important link between inflammation and the outcome of TBI patients. Using serum and mRNA from white blood cells (WBC) of TBI patients, we found a positive correlation between serum SAA1 levels and injury severity, as well as with the 6-month outcome of TBI patients. SAA1 levels also correlate with the presence of TLR4 mRNA in WBC. In vitro, we found that SAA1 contributes to inflammation via TLR4 activation that releases inflammatory cytokines, which in turn increases SAA1 levels, establishing a positive proinflammatory loop. In vivo, post-TBI treatment with the TLR4-antagonist TAK242 reduces SAA1 levels, improves neurobehavioral outcome, and prevents blood–brain barrier disruption. Our data support further evaluation of (i) post-TBI treatment in the presence of TLR4 inhibition for limiting TBI-induced damage and (ii) SAA1-TLR4 as a biomarker of injury progression in TBI patients.
- 25 May 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (6) , 599
Open AccessSerum Amyloid A1/Toll-Like Receptor-4 Axis, an Important Link between Inflammation and Outcome of TBI Patients
Traumatic brain injury (TBI) is one of the leading causes of mortality and disability worldwide without any validated biomarker or set of biomarkers to help the diagnosis and evaluation of the evolution/prognosis of TBI patients. To achieve this aim, a deeper knowledge of the biochemical and pathophysiological processes triggered after the trauma is essential. Here, we identified the serum amyloid A1 protein-Toll-like receptor 4 (SAA1-TLR4) axis as an important link between inflammation and the outcome of TBI patients. Using serum and mRNA from white blood cells (WBC) of TBI patients, we found a positive correlation between serum SAA1 levels and injury severity, as well as with the 6-month outcome of TBI patients. SAA1 levels also correlate with the presence of TLR4 mRNA in WBC. In vitro, we found that SAA1 contributes to inflammation via TLR4 activation that releases inflammatory cytokines, which in turn increases SAA1 levels, establishing a positive proinflammatory loop. In vivo, post-TBI treatment with the TLR4-antagonist TAK242 reduces SAA1 levels, improves neurobehavioral outcome, and prevents blood–brain barrier disruption. Our data support further evaluation of (i) post-TBI treatment in the presence of TLR4 inhibition for limiting TBI-induced damage and (ii) SAA1-TLR4 as a biomarker of injury progression in TBI patients.